Guangzhou LBP Medicine Science & Technology Co., Ltd. (688393.SS)
CNY 32.0
(7.02%)
CNY 32.0
(7.02%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 28.38 Million CNY | 14.44% |
| 2022 | 24.8 Million CNY | 100.18% |
| 2021 | 12.39 Million CNY | 598.69% |
| 2020 | 1.77 Million CNY | 0.0% |
| 2019 | - CNY | 0.0% |
| 2018 | - CNY | 0.0% |
| 2017 | - CNY | 0.0% |
| 2016 | - CNY | 0.0% |
| 2013 | 10.27 Million CNY | 0.0% |
| 2012 | - CNY | 0.0% |
| 2011 | - CNY | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q3 | 7 Million CNY | -22.44% |
| 2024 Q1 | 8.5 Million CNY | -70.03% |
| 2024 Q2 | 14.08 Million CNY | 65.61% |
| 2023 Q2 | 15.32 Million CNY | -38.42% |
| 2023 Q3 | 21.14 Million CNY | 37.99% |
| 2023 Q1 | 24.88 Million CNY | 0.32% |
| 2023 FY | 28.38 Million CNY | 14.44% |
| 2023 Q4 | 28.38 Million CNY | 34.26% |
| 2022 Q2 | 12.27 Million CNY | -6.33% |
| 2022 Q1 | 13.1 Million CNY | 5.74% |
| 2022 FY | 24.8 Million CNY | 100.18% |
| 2022 Q4 | 24.8 Million CNY | 10.03% |
| 2022 Q3 | 22.54 Million CNY | 83.68% |
| 2021 Q1 | 1.86 Million CNY | 5.44% |
| 2021 Q3 | 2.88 Million CNY | -20.23% |
| 2021 FY | 12.39 Million CNY | 598.69% |
| 2021 Q4 | 12.39 Million CNY | 329.26% |
| 2021 Q2 | 3.61 Million CNY | 93.52% |
| 2020 Q4 | 1.77 Million CNY | 0.0% |
| 2020 Q2 | - CNY | 0.0% |
| 2020 Q1 | - CNY | 0.0% |
| 2020 FY | 1.77 Million CNY | 0.0% |
| 2020 Q3 | - CNY | 0.0% |
| 2019 Q2 | - CNY | 0.0% |
| 2019 FY | - CNY | 0.0% |
| 2019 Q4 | - CNY | 0.0% |
| 2018 FY | - CNY | 0.0% |
| 2017 FY | - CNY | 0.0% |
| 2016 FY | - CNY | 0.0% |
| 2014 Q3 | 10.96 Million CNY | 0.0% |
| 2013 FY | 10.27 Million CNY | 0.0% |
| 2012 FY | - CNY | 0.0% |
| 2011 FY | - CNY | 0.0% |